Study of Salirasib to Treat Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Salirasib is effective to shrink or prevent
the growth of the tumors associated with non-small cell lung cancer in both patients who are
newly diagnosed or have recurrent disease.